Objective: To examine the effects of the degree of body mass index and weight gain as the risks for hypertension, hypercholesterolemia and diabetes in Japanese men, and to compare that to the corresponding effects in a Caucasian population. Design: Prospective cohort study. Setting: Cohort of all male employees at a company. Subjects: A total of 4737 male employees followed until retirement or for 4 y (longest term 4 y). Results: Increase of body mass index beyond 22 kg=m 2 related to an increased risk for hypertension even after being adjusted for possible confounding factors such as age, smoking status, alcohol intake, family history and baseline value of systolic blood pressure. The risks greatly increased in subjects with a body mass index above 27 kg=m 2 for hypertension, and 29 kg=m 2 for diabetes and hypercholesterolemia. Weight gain (more than 2 kg) was strongly related to an increased risk for hypertension and hypercholesterolemia after being adjusted for possible confounding factors. However, weight gain was not related to diabetes, and weight loss did not decrease the risks for any of the three diseases. Conclusions: Among Japanese, the degrees of body mass index associated with risks for hypertension, diabetes and hypercholesterolemia were lower than those in Caucasians. The risks for hypertension and hypercholesterolemia were strongly associated with weight gain in a Japanese male population who showed a low prevalence of severe obesity, and the risks were similar to or somewhat higher than those in a Caucasian population with a high prevalence of severe obesity.
Introduction
Obesity is often associated with type 2 diabetes, hypertension and hyperlipidemia, which consequently result in coronary heart disease (CHD). According to a report of the World Health Organization (WHO), risks for type 2 diabetes and dyslipidaemia are greatly increased in obese subjects (relative risk, more than three times), and those of CHD and hypertension are also increased (relative risk, two to three times; WHO, 1998) . Although there are several studies examining the relationship between obesity and the incidence of these diseases, most of them have examined Caucasians (Huang et al, 1998; Chan et al, 1994; Colditz et al, 1990; Helmrich et al, 1991; Manson et al, 1992; Rimm et al, 1995) . Since Asian populations, including Japanese, have a much lower body mass index (BMI) than Caucasians (Flegal et al, 1998; Liu et al, 1999; Ministry of Health and Welfare in Japan, 1996) , an underlying question is how data on the relationship between BMI and the incidence of these diseases, and on the effect of weight gain on these diseases in Asian populations, compare to corresponding data for Caucasians.
Several cross-sectional studies have indicated that the relationship between an increase in BMI and mortality or morbidity in Japanese was similar to that in Caucasians (Liu et al, 1999; Todoroki et al, 1994; Tokunaga et al, 1991; Nakayama et al, 1997) . However, there is only one prospective study, to our knowledge, that has examined the effect of an increase in BMI on the incidence of hypertension and type 2 diabetes in Asian populations (Tai et al, 1992) . Furthermore, the effect of weight gain during adulthood has not been examined among Japanese, who have a historically low prevalence of severe obesity.
The present study was the first to prospectively examine the effects of an increase in BMI and weight gain on the incidence of hypertension, type 2 diabetes and hypercholesterolemia in Japanese men initially without any of these abnormalities.
Subjects and methods

Subjects
Participants were male employees of a company with a head office, 36 branches, and 12 factories all over Japan. In 1994, 8823 employees of that company (7560 male, 1263 female) took regular physical check-ups. Among the total of 7560 male employees, 14% (n ¼ 1058) were office workers, and the other 86% (n ¼ 6502) were factory workers. Sixty-one people with a history of ischemic heart disease, cancer or cerebrovascular accident were excluded. In addition, we excluded 1066 men who worked alternate day and night shifts because they showed a higher prevalence of comorbidity than daytime workers, as well as 1686 men with data missing from their baseline physical checkup. We also excluded 10 men with BMI of more than 35 kg=m 2 at baseline because of their small number. This left 4737 qualified subjects, all of whom underwent a regular annual physical checkup and were followed until retirement (1 -4 y) or up to 1998, whichever came first.
In an analysis of the incidence of hypertension, we excluded a further 733 men who already had an above normal blood pressure at baseline among the 4737 men. The normal range for blood pressure was defined as systolic < 130 mmHg and diastolic < 85 mmHg according to the criteria of the 6th report of the Joint National Committee of Detection and Evaluation for Hypertension (JNC VI), or subjects not taking medication for hypertension (The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, 1997) . In an analysis of the incidence of diabetes, we excluded 352 men who already had above-normal fasting plasma glucose at baseline. The normal range for fasting plasma glucose was defined as < 110 mg=dl according to the criteria of the Japan Diabetic Society, or those not taking medication for diabetes (Japan Diabetic Society, 1999 ). In the analysis of incidence of hypercholesterolemia, we excluded another 1742 men who already had an above-normal total plasma cholesterol at baseline. The normal range for total plasma cholesterol was defined as < 200 mg=dl by the criteria of Japan Arteriosclerosis Society, or persons not taking medication for hyperlipidemia (Japan Arteriosclerosis Society, 1997). Overall, 3994, 4385 and 2995 men were analyzed for risk of hypertension, diabetes and hypercholesterolemia, respectively.
Physical checkup
The annual physical checkup consisted of physical examinations, anthropometric measurements (height and body weight), and measurements of blood pressure, fasting plasma glucose and lipids. BMI was calculated by weight in kilograms divided by the height squared in meters. Resting blood pressure was obtained in duplicate after at least a 5 min rest using a sphygmomanometer. Venous blood was drawn for measurements after an overnight fast, and analyzed at a central laboratory (Mitsubishi Kagaku Bio-Clinical Laboratories Inc., Tokyo, Japan). Each subject filled out a questionnaire of medical history family history and health-related behaviors such as physical activity, smoking and daily alcohol consumption. Physicians and nurses employed by the company conducted all measurements.
Criteria of hypertension, diabetes and hypercholesterolemia Hypertension, diabetes and hypercholesterolemia were diagnosed at the annual physical checkup. Hypertension was defined by the criteria of JNC VI (systolic blood pressure ! 140 and=or diastolic blood pressure ! 90 mmHg) or by the use of antihypertensive medication (The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 1997). Diabetes was defined by the criteria of the Japan Diabetes Association (fasting blood glucose ! 126 mg=dl) or by taking medication for diabetes (Japan Diabetic Society, 1999) . Hypercholesterolemia was defined by the criteria of the Japan Arteriosclerosis Society (total plasma cholesterol ! 220 mg=dl) or by taking medication for hyperlipidemia (Japan Arteriosclerosis Society, 1997).
Statistical analysis
Person-years for each man for hypertension, diabetes or hypercholesterolemia were estimated from the day of his first regular physical checkup in 1994 (baseline) to the day when one of these diseases was diagnosed, to his retirement year, or to 1998, whichever came first. Subjects were classified into underweight (BMI < 18.5 kg=m 2 ), normal (BMI < 25 kg=m 2 ), obesity I (BMI ! 25 kg=m 2 and < 30 kg=m 2 ), and obesity II (BMI ! 30 kg=m 2 and < 35 kg=m 2 ) at baseline using the criteria of the Japan Society for the Study of Obesity (Matsuzawa et al, 2000) . Normal and obesity I subjects were further categorized into 12 BMI groups using a whole-number cut-off point. In addition, to examine the effect of changes in body weight, men were classified into three levels: weight change within 2 kg; and weight loss or Obesity, weight change and disease risk K Ishikawa-Takata et al gain of more than 2 kg as designated in the previous study (Huang et al, 1998) . Incidence rates were obtained by dividing the number of cases by person-years in each classified category (BMI or weight change).
Multivariate Cox proportional hazards regression analysis was used to adjust simultaneously for age (1 y categories), smoking status (never, past, current), alcohol intake (never, less than three times per week, more than three times per week), family history (yes or no), and baseline measurements (systolic blood pressure, fasting plasma glucose, or total plasma cholesterol). In addition, relative risk was also adjusted for BMI at baseline to examine the effect of body weight changes independent of the initial BMI.
Results Table 1 illustrates baseline characteristics according to BMI category at the start of this study. During a 4 y follow-up period, newly diagnosed cases numbered 662 (46.7 per 1000 person-years), 242 (14.7 per 1000 person-years), and 251 (22.6 per 1000 person-years) for hypertension, diabetes and hypercholesterolemia, respectively.
The age-adjusted risk for hypertension increased as BMI increased ( Table 2 ). The risk in subjects with a BMI above 20 kg=m 2 was significantly higher than subjects with a BMI below 18.5 kg=m 2 . The risk more than doubled with BMIs above 21 kg=m 2 , more than tripled with BMIs above 24 kg=m 2 , and increased four-fold when BMI exceeded 27 kg=m 2 . After adjustments for age, smoking status, alcohol intake, family history of hypertension and baseline value of systolic blood pressure, the relative risk was only slightly attenuated and remained significant in all subjects with BMIs of more than 22 kg=m 2 . It showed a much higher risk for subjects with BMI of more than 27 kg=m 2 , even after adjusting for possible confounding factors.
The age-adjusted risk for diabetes was not different between subjects with BMI ranging from 18.5 to 27 kg=m 2 and those with BMI < 18.5 kg=m 2 (Table 3) . However, subjects with BMI between 27 and 29 kg=m 2 had a two-fold higher relative risk than subjects with BMI < 18.5 kg=m 2 , and the risk was dramatically increased in subjects with BMI of more than 29 kg=m 2 . After adjusting for the possible confounding factors, the multivariate risk was only slightly attenuated, but the higher risk remained significant in subjects with BMI above 29 kg=m 2 . The age-adjusted risk for hypercholesterolemia increased as BMI increased (Table 4 ). The risks proved to be two-fold higher in subjects with BMI above 21 kg=m 2 , and more than three times higher in subjects with BMI above 25 kg=m 2 . The Obesity, weight change and disease risk K Ishikawa-Takata et al risks dramatically increased in subjects with BMI of more than 29 kg=m 2 . Although the risk was attenuated after multivariate adjustment, it remained significant in subjects with BMI above 29 kg=m 2 . The relative risks for hypertension, diabetes and hypercholesterolemia as classified by weight change are shown in Table 5 . Only 1.9% of subjects decreased their body weight by more than 5 kg, and 8.5% of subjects increased their body weight by more than 5 kg during the 4 y follow-up period. When we consider the group with stable weight (weight change 2 kg) as a referent, weight losses were not related to the risk for these diseases. In contrast, weight gains were related to increased risk for hypertension and hypercholesterolemia. The age-adjusted risk for these diseases in subjects gaining more than 2 kg of body weight increased 1.26 times for hypertension and 2.17 times for hypercholesterolemia compared to subjects maintaining stable weight. The risk was not altered after adjustment of baseline BMI in 1994. After adjustments for age, BMI, smoking status and other possible confounding factors, this relative risk was slightly attenuated, but still significantly increased in subjects gaining more than 2 kg. In contrast, the risk for diabetes was not related to weight gain after adjusting for possible confounding factors. Adjusted for age (1 y categories), smoking status (never, past, current), alcohol intake (never, less than three times per week, more than three times per week), family history, and baseline value of fasting blood glucose. Adjusted for age (1-y categories), smoking status (never, past, current), alcohol intake (never, less than three times per week, more than three times per week), family history, and baseline value of fasting total cholesterol.
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Discussion
In the present study, we found that an increase in BMI even in the normal-weight and obesity I groups was associated with an increased risk for hypertension and hypercholesterolemia. This remained true even after adjustments for several confounding factors. The risk was greatly increased in subjects with BMI of more than 27 kg=m 2 for hypertension, and more than 29 kg=m 2 for diabetes and hypercholesterolemia. Although weight gain (more than 2 kg) was related to an increased risk for hypertension and hypercholesterolemia after adjustments for several confounding factors, it was not related to the risk for diabetes. Weight loss was not related to risks for any of the three diseases.
The distribution of BMI in the present study was similar to that in the National Nutrition Survey and National Crosssectional Surveys on Circulatory Disorders in Japanese (Ministry of Health and Welfare in Japan, 1996; Liu et al, 1999) . Thus, our BMI distribution results can be considered representative of the Japanese population. Among the subjects, 11.6 -16.6% were classified as obesity I (BMI 25 to < 30 kg=m 2 ), and only 0.6 -1.0% as obesity II (BMI ! 30 to < 35 kg=m 2 ) according to the criteria of the Japan Society for the Study of Obesity (Matsuzawa et al, 2000) , both of which were considered a low prevalence of obesity by the WHO classification (WHO, 1998) . Although excluded from the analysis, there were only 10 subjects with BMI above 35 kg=m 2 . The proportion of severe obesity was very much smaller in our subjects than in the US population (Flegal et al, 1998) , as noted in the results of a National Nutrition Survey in Japan (Ministry of Health and Welfare in Japan, 1996) .
According to the report of WHO, the risk for hypertension was moderately increased (relative risk, two to three times) in subjects with a BMI of more than 30 kg=m 2 (WHO, 1998). However, other studies found a two to three times higher risk in men with BMI more than 24 or 26 kg=m 2 in US and Chinese populations (Willett et al, 1999; Huang et al, 1998; Tai et al, 1992) . The present results indicated that the ageadjusted risk for hypertension increased consecutively in subjects with BMI more than 20 kg=m 2 : it became three times higher in those with BMI more than 24 kg=m 2 , and four times higher in those with BMI above 27 kg=m 2 . Although the risk was attenuated after adjusting for several confounding factors, it remained significant in subjects with Obesity, weight change and disease risk K Ishikawa-Takata et al BMI above 22 kg=m 2 . Thus, we may presume that the increased risk for hypertension in Japanese seems to require a lower BMI compared with that in Caucasian populations.
The WHO reports indicated that the risk for diabetes increased three times in subjects with BMI more than 30 kg=m 2 (WHO, 1998) . Willet et al (1999) reported that the risk for diabetes was four times higher in men with BMI of 26 kg=m 2 than those with BMI less than 21 kg=m 2 , and that in men with BMI more than 29 kg=m 2 the risk was greatly increased. Tai et al (1992) found that the risk for diabetes in Chinese men with BMI above 25.27 kg=m 2 was 2.87 times higher than those with BMI below 21.26 kg=m 2 . In the present study, the risk for diabetes in subjects with BMI less than 29 kg=m 2 was not significant. However, it increased dramatically in subjects with BMI of more than 29 kg=m 2 . That dramatic increase is similar to the results of Willet et al (1999) . On the other hand, the present study showed that risk for diabetes in subjects with BMI less than 29 kg=m 2 is lower than that for Caucasians and Chinese. Although the reason for this difference was unclear, differences in lifestyle or race might be important factors.
To our knowledge, there is no study examining the effect of the obesity on the incidence of hypercholesterolemia. Age-adjusted risk for hypercholesterolemia in subjects with BMI from 25 to 29 kg=m 2 was similar to the risk for dyslipidemia in subjects with BMI more than 30 kg=m 2 as shown in the 1998 report of WHO. In the present study, the risk for subjects with BMI from 25 to 29 kg=m 2 was not significant after adjustment for several confounding factors. That lack of significance was probably due to a correction of cholesterol at baseline by multivariate adjustment. However, the risk in subjects with BMI above 29 kg=m 2 remained significant even after adjustment for confounding factors, and it remained more than four times higher.
There is a possibility that overweight younger and older adults have different risks for these diseases. Since the age distribution of our subjects was wide (18 -59 y), we examined the interaction between age and BMI for evidence of risk of these diseases. The results showed that only hypertension had a positive interaction of age and BMI, suggesting that overweight in older subjects posed more of a risk for that disease than in younger subjects. On the other hand, we found no interaction between age and BMI on the risk for diabetes and hypercholesterolemia.
Recent studies described the effect of changes in body weight on the incidence of obesity-related diseases (Huang et al, 1998; Chan et al, 1994) . As for the risk of hypertension, Huang et al (1998) indicated that, among women 30 -55 y of age, the relative risk increased about 1.3 times in subjects with body weight gains of 2.1 -4.9 kg compared with that in subjects whose body weight changes were less than 2 kg during the long-term (12 -50 y) and medium-term (2 -14 y). The effects of weight gain on the incidence of hypertension in our study was similar to those in Huang et al (1998) .
In the present study, the effect of weight gain on the risk of diabetes was not significant. In Chan's study, that risk for subjects who gained 4.5 -13.6 kg was only 1.7 times higher compared with that of the subjects who showed a weight change of less than 4.5 kg. Among our subjects, only 8.5% increased their body weight more than 5 kg. Then great gain of body weight or higher initial BMI might affect the increase of risk for diabetes.
We found no study that examined the effect of weight changes on the risk of hypercholesterolemia. The present study indicated that gaining weight also significantly increased the risk for hypercholesterolemia (over two-fold more than stable weight). The risk was higher than that for hypertension and was not altered even after adjustment for initial body weight or other confounding factors. Therefore, we assume that weight gain is one of the major risk factor for hypercholesterolemia.
The effect of weight gain on the risks discussed was independent of the degree of BMI at the baseline for hypertension and hypercholesterolemia. These results suggest that the effect of weight gains among Japanese who show a low prevalence of severe obesity was similar to or somewhat higher than that in the US population, which shows a high prevalence.
We found that weight loss did not affect any of the three diseases (1.9% of subjects decreased their body weight more than 5 kg, but most lost less than 5 kg). Huang et al (1998) reported that a loss of more than 5 kg of weight was related to a reduced risk for hypertension. We consider that the reason for detecting no adverse association between weight loss and the risk for diseases in our subjects was the very small weight loss.
In summary, the results suggested that it is beneficial for Japanese who show a low prevalence of severe obesity to keep BMI within 18.5 and 25 kg=m 2 , and to maintain a stable body weight (within 2 kg change) for the prevention of hypertension, diabetes and hypercholesterolemia.
